Clinical Trial Update: Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety study of DP-b99 for acute ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DP-b99 (DP-b99)

Snippet

Sponsor: D-Pharm Ltd. | Conditions: Acute Ischemic Stroke | Phase 3 | Status: TERMINATED